No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Medical Imaging Corporation, actively operating in China, specializes in providing leasing and management solutions for medical imaging technology. Its comprehensive product portfolio includes sophisticated diagnostic devices such as ultrasound equipment and bone density detectors. Beyond imaging, the company also supplies specialized medical infrastructure like emergency rooms and intensive isolation wards, along with advanced intelligent lead plates for radiation protection. Additionally, it engages in the wholesale distribution of a wide range of medical equipment and pharmaceuticals. The company was founded in 1978 and maintains its headquarters in Taipei, Taiwan.
www.mic-tw.comNo one on the platform currently holds 6637.TWO.
No tracked institution reports a position in 6637.TWO as of their last filing.
No one on the platform has traded 6637.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 14.7% | 21.7% | — | — | — | |
| Rev. Growth % | 40.5% | 16.4% | ||||
| Profit Margin % | 15.9% | 17.8% | ||||
| Free Cash Flow Margin % | -27.7% | 12.6% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.2B | +11.3% | $6.76 | $6.76–$6.76 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-11 | $1.52 | $1.01 | -33.6% |
| 2026-03-09 | $0.70 | $1.39 | +98.6% |
| +1.02% |
| $2.1B |
| — |
| 6527.TWOCrystalvue Medical Corporation | $75.20 | +0.27% | $1.9B | — |
| 6598.TWApplied BioCode Corporation | $27.40 | +0.92% | $2.8B | — |
Source: Financial Modeling Prep · peers by sector/industry